Jan 24th, 2024
Don't miss today's Late-Breaking Science at the Closing Event
Don't miss these 10 important Late-Breaking Science presentations.
Closing Main Event | 11 a.m.-1:30 p.m. | Main Event Hall, Halls 1-3
- The EMBOLISE Study: Embolization of the Middle Meningeal Artery With OnyxTM Liquid Embolic System in the Treatment of Subacute and Chronic Subdural Hematoma
- The MAGIC-MT Trial: Managing Non-Acute Subdural Hematoma Using Liquid Materials: A Chinese Randomized Trial of Middle Meningeal Artery Treatment
- Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study
- STEM (The Squid Trial for the Embolization of the MMA for the Treatment of CSDH)
- Delayed Therapy With Humanized Anti-Sdc2 mAb Prevents Formation of Vasogenic Edema and Promotes Neuroprotection in Non-Human Primates With Ischemic Stroke
- Tenecteplase Thrombolysis for Stroke Up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial
- Machine Learning Algorithms for Autonomous Detection of Stroke Symptoms and Bell's Palsy
- Reteplase Treating Patients With Acute Ischemic Stroke (RAISE): A Phase 3, Multicenter, Open-Label, Randomized Controlled, Non-Inferiority Trial
- Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke or Transient Ischemic Attack: The INSPIRES Randomized Clinical Trial
- Long-Term Outcomes and EVT Treatment Effect From Randomized Controlled Trial of Endovascular Thrombectomy for Large Ischemic Strokes: SELECT2
Click here for more information about Late-Breaking Science and Concurrent Oral Abstract Sessions at ISC24.
